Floatz logo

Cart22 Cells

Prostate Neoplasms

Cougar Biotechnology, Inc.Cell therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Prostate Neoplasms cohort.

Asset / SponsorPhaseRating
Zoladex
Wonju Severance Christian Hospital
Phase 4BB
Bortezomib
Millennium Pharmaceuticals, Inc.
Phase 2BB
FLUDEOXYGLUCOSE
National Cancer Institute (NCI)
Phase 2B
17-beta-estradiol
University of Washington
Phase 2B
Azacitidine
Icahn School of Medicine at Mount Sinai
Phase 2B

View all 16 →

Same molecule, other indications

Cart22 Cells is also rated in:

Astrocytic TumorsDormant
CC
Indicative ·
47 / 100
View asset →
Glioblastoma MultiformeDormant
CC
Indicative ·
44 / 100
View asset →
Anaplastic AstrocytomaDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →